Hanmi Pharm. Co.

128940.KO

183.32 USD

-0.37

-0.20%

Overview

Last close

183.32 usd

Market cap

2.32B usd

52 week high

279.68 usd

52 week low

170.90 usd

Target price

273.99 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

2.1581

Price/Book Value

3.1312

Enterprise Value

2.52B usd

EV/Revenue

2.352

EV/EBITDA

10.5417

Key financials

Revenue TTM

1.08B usd

Gross Profit TTM

492.44M usd

EBITDA TTM

249.62M usd

Earnings per Share

N/A usd

Dividend

0.51 usd

Total assets

1,975.73B usd

Net debt

N/A usd

About

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.